Priser
Platform
Blog
Om os
Download
300463
Maccura Biotechnology Co
Shenzhen Stock Exchange
0

Om

Maccura Biotechnology Co., Ltd. is a leading company in the biotechnology and medical devices sector. The primary function of Maccura is to develop, manufacture, and market innovative diagnostic reagents and instruments. These products are aimed at providing high-quality, reliable solutions for clinical and commercial laboratories, significantly impacting healthcare diagnostics. Maccura operates in a critical intersection between biotechnology and healthcare, focusing on expanding the availability of diagnostic technologies that enhance patient care and treatment outcomes. With a strong emphasis on research and development, the company continuously seeks advancements in molecular diagnostics, chemiluminescence, and immunoassay technologies. Maccura’s significant market role is underscored by its commitment to quality and its ability to meet the stringent regulatory standards of the medical diagnostics industry.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I MACCURA BIOTECHNOLOGY CO MED ENDAVU: Køb Maccura Biotechnology Co ($300463) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Maccura Biotechnology Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker300463
Land
Kina
Antal medarbejdere3.472
Hjemmesidemaccura.com
SektorSundhed
IndustriDiagnostik og forskning

Udbytter

0,19CNH
'20
0,43CNH
'21
0,47CNH
'22
0,35CNH
'23
0,15CNH
'24
0,1CNH
'25
Ex-udbytte-dato28. maj 2025
Udbytteafkast0,99%

Analytikerskøn

Baseret på 2 analytikere

Stærkt købKøbHoldSælgStærkt sælg
0%100%0%0%0%